| Covariate | Inpatient bleeders (n=96) | Outpatient bleeders (n=274) | p Value |
| Age, years, (median, IQR) | 77 (67–83) | 68 (50–79) | <0.001 |
| Males | 44/96 (45.8%) | 166/274 (60.6%) | 0.016 |
| Cardiovascular disease | 50/96 (52.1%) | 80/274 (29.2%) | <0.001 |
| Rockall 3+ | 81/96 (84.4%) | 182/273 (66.7%) | 0.001 |
| Aspirin | 44/96 (45.8%) | 86/274 (31.4%) | 0.013 |
| Other antithrombotics | 35/96 (36.5%) | 50/274 (18.2%) | <0.001 |
| Aspirin or other antithrombotics | 62/96 (64.6%) | 122/274 (44.5%) | 0.001 |
| NSAIDs | 11/96 (11.5%) | 49/273 (17.9%) | 0.15 |
| Death at 30 days | 9/94 (9.6%) | 12/272 (4.4%) | 0.074 |